Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Allergic Conjunctivitis”

6 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 6 of 6 results

Post-approval studies (Phase 4)Study completedNCT01730872
What this trial is testing

Evaluation of Prednisolone in a Modified Conjunctival Allergen Challenge Model

Who this might be right for
Chronic Allergic Conjunctivitis
ORA, Inc. 16
Not applicableStudy completedNCT06063044
What this trial is testing

Food-specific IgG4-guided Elimination Diets Improve Allergy Symptoms in Children

Who this might be right for
Rhinitis, AllergicAsthma, AllergicConjunctivitis, Allergic+2 more
Second Affiliated Hospital, School of Medicine, Zhejiang University 407
Testing effectiveness (Phase 2)Study completedNCT03320434
What this trial is testing

Study Evaluating the Efficacy and Safety of PRT-2761 for the Treatment of Acute and Chronic Allergic Conjunctivitis

Who this might be right for
Allergic Conjunctivitis
ORA, Inc. 120
Large-scale testing (Phase 3)Study completedNCT02988882
What this trial is testing

OTX-15-002: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis

Who this might be right for
Chronic Allergic Conjunctivitis
Ocular Therapeutix, Inc. 86
Testing effectiveness (Phase 2)Study completedNCT02062905
What this trial is testing

OTX-14-001: A Phase 2 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis

Who this might be right for
Chronic Allergic Conjunctivitis
Ocular Therapeutix, Inc. 68
Large-scale testing (Phase 3)Study completedNCT02445326
What this trial is testing

OTX-14-007: A Phase 3 Study Evaluating the Safety and Efficacy of OTX-DP for the Treatment of Chronic Allergic Conjunctivitis

Who this might be right for
Chronic Allergic Conjunctivitis
Ocular Therapeutix, Inc. 73